Lotus Eye Hospit

Market Cap: Micro Cap
Industry: Hospital
ISIN: INE947I01017
NSEID: LOTUSEYE
BSEID: 532998
View on NSE | View on BSE

INR

109.25

1.05 (0.97%)

BSENSE

Jun 03, 03:30 PM

BSE+NSE Vol: 8.33 k

{
  "main_header": {
    "sid": 959118,
    "name": "Lotus Eye Hospit",
    "stock_name": "Lotus Eye Hospit",
    "full_name": "Lotus Eye Hospital & Institute Ltd",
    "name_url": "stocks-analysis/lotus-eye-hospit",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "109.25",
    "chg": 1.05,
    "chgp": "0.97%",
    "dir": 1,
    "prev_price": "108.20",
    "mcapval": "227.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 532998,
    "symbol": "LOTUSEYE",
    "ind_name": "Hospital",
    "ind_code": 94,
    "sector_id": 38,
    "indexname": "India SENSEX",
    "isin": "INE947I01017",
    "curr_date": "Jun 03, 03:30 PM",
    "curr_time": "01:05 AM",
    "last_traded_at": "Jun 03, 03:30 PM IST",
    "bse_nse_vol": "8.33 k",
    "exc_status": "Active",
    "traded_date": "Jun 03, 2026",
    "traded_date_str": "2026 06 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/lotus-eye-hospit-959118-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Lotus Eye Hospital Gains 0.93%: 4 Key Factors Driving the Week’s Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lotus-eye-hospital-gains-093-4-key-factors-driving-the-weeks-volatility-4022963",
        "imagepath": "",
        "date": "2026-05-30 14:00:07",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>25 May:</strong> Stock opens steady at Rs.107.05 with Sensex rallying 1.23%</p>\n                    <p><strong>26 May:</strong> Sharp stock gain of 3.69% to Rs.111.00 despite Sensex decline</p>\n                    <p><strong>27 May:</strong> Q4 FY26 results reveal profitability crisis; stock dips 1.62%</p>\n                    <p><strong>29 May:</strong> Downgrade to Strong Sell and quality deterioration weigh; stock closes at Rs.108.05 (-1.05%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.107.05</div></div>\n                    <div class=\"stat-item\"><..."
      },
      {
        "title": "Lotus Eye Hospital & Institute Ltd: Valuation Shifts Signal Elevated Risk Amid Price Attractiveness Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lotus-eye-hospital-institute-ltd-valuation-shifts-signal-elevated-risk-amid-price-attractiveness-decline-4019291",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/LotusEyeHospita_valuationdot_4019291.png",
        "date": "2026-05-29 08:02:29",
        "description": "Lotus Eye Hospital & Institute Ltd has seen a marked shift in its valuation parameters, moving from a 'very expensive' to a 'risky' grade, driven by an extraordinary surge in its price-to-earnings ratio and other key multiples. This change signals a significant reassessment of the stock’s price attractiveness relative to its historical and peer benchmarks within the hospital sector."
      },
      {
        "title": "Lotus Eye Hospital & Institute Ltd Downgraded to Strong Sell Amid Deteriorating Quality Metrics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lotus-eye-hospital-institute-ltd-downgraded-to-strong-sell-amid-deteriorating-quality-metrics-4019123",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/LotusEyeHospita_qualitydot_4019123.png",
        "date": "2026-05-29 08:00:20",
        "description": "Lotus Eye Hospital & Institute Ltd has seen a significant downgrade in its quality grading from average to below average, prompting MarketsMOJO to revise its rating from Sell to Strong Sell as of 27 May 2026. This shift reflects a marked deterioration in key business fundamentals including profitability ratios, debt metrics, and operational consistency, raising concerns for investors despite the stock’s strong long-term returns relative to the Sensex."
      },
      {
        "title": "Lotus Eye Hospital & Institute Ltd Downgraded to Strong Sell Amid Deteriorating Fundamentals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/lotus-eye-hospital-institute-ltd-downgraded-to-strong-sell-amid-deteriorating-fundamentals-4017795",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/LotusEyeHospita_mojoScore_4017795.png",
        "date": "2026-05-28 08:27:14",
        "description": "Lotus Eye Hospital & Institute Ltd has seen its investment rating downgraded from Sell to Strong Sell as of 27 May 2026, reflecting deteriorating fundamentals across multiple parameters including quality, valuation, financial trends, and technical indicators. The micro-cap hospital sector stock’s recent performance and financial metrics have raised significant concerns among analysts, prompting a reassessment of its outlook."
      },
      {
        "title": "Are Lotus Eye Hospital & Institute Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-lotus-eye-hospital-institute-ltd-latest-results-good-or-bad-4017435",
        "imagepath": "",
        "date": "2026-05-27 20:24:10",
        "description": "Lotus Eye Hospital & Institute Ltd's latest financial results for Q4 FY26 present a complex picture of the company's operational performance. The hospital reported net sales of ₹13.61 crores, reflecting an 18.25% increase year-on-year and a marginal 0.44% growth from the previous quarter. This marks the highest quarterly revenue in the company's recent history, indicating sustained patient demand at its Coimbatore facility.\n\nHowever, this top-line growth has not translated into profitability, as the company recorded a net loss of ₹0.32 crores, a significant shift from a profit of ₹0.25 crores in the same quarter last year. The operating margin has also seen a notable decline, falling to 3.53% from 10.95% in Q1 FY26, highlighting ongoing challenges in managing operational costs effectively. The profit before tax turned negative at ₹0.48 crores, underscoring the erosion of profitability despite the revenue gr..."
      },
      {
        "title": "Lotus Eye Hospital Q4 FY26: Profitability Crisis Deepens Amid Revenue Growth",
        "link": "https://www.marketsmojo.com/news/result-analysis/lotus-eye-hospital-q4-fy26-profitability-crisis-deepens-amid-revenue-growth-4017109",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/LotusEyeHospita_quaterlyResult_4017109.png",
        "date": "2026-05-27 11:51:36",
        "description": "Lotus Eye Hospital & Institute Ltd. reported a troubling Q4 FY26 performance, slipping into losses despite achieving its highest-ever quarterly revenue. The Coimbatore-based speciality eye care provider posted a net loss of ₹0.32 crores for the quarter ended March 2026, marking a sharp reversal from the ₹0.25 crores profit recorded in the corresponding quarter last year. The stock has declined 0.38% following the results announcement, trading at ₹109.00 and reflecting investor concerns about deteriorating profitability."
      },
      {
        "title": "Lotus Eye Hospital & Institute Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/lotus-eye-hospital-institute-ltd-is-rated-sell-3998897",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/LotusEyeHospita_mojoScore_3998897.png",
        "date": "2026-05-19 10:10:22",
        "description": "Lotus Eye Hospital &amp; Institute Ltd is rated Sell by MarketsMOJO. This rating was last updated on 07 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 May 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Lotus Eye Hospital & Institute Ltd Falls 1.20%: Downgrade and Death Cross Signal Weigh on Stock",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lotus-eye-hospital-institute-ltd-falls-120-downgrade-and-death-cross-signal-weigh-on-stock-3983260",
        "imagepath": "",
        "date": "2026-05-09 14:04:25",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>May 7:</strong> Death Cross formation signals potential bearish trend</p>\n                    <p><strong>May 7:</strong> Stock rallies 2.77% intraday following technical signal</p>\n                    <p><strong>May 8:</strong> Downgrade to Sell rating by MarketsMOJO</p>\n                    <p><strong>May 8:</strong> Week closes at Rs.115.05, down 1.20%</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.116.45</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.115.05</div><div class=\"sta..."
      },
      {
        "title": "Lotus Eye Hospital & Institute Ltd Downgraded to Sell Amid Mixed Fundamentals and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/lotus-eye-hospital-institute-ltd-downgraded-to-sell-amid-mixed-fundamentals-and-technical-signals-3980958",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/LotusEyeHospita_mojoScore_3980958.png",
        "date": "2026-05-08 08:20:46",
        "description": "Lotus Eye Hospital & Institute Ltd has seen its investment rating downgraded from Hold to Sell as of 7 May 2026, reflecting a combination of deteriorating technical indicators, expensive valuation metrics, flat financial trends, and concerns over quality parameters. Despite a strong stock price performance over the past year, the company faces challenges that have prompted a reassessment of its investment appeal."
      }
    ],
    "total": 184,
    "sid": "959118",
    "stock_news_url": "https://www.marketsmojo.com/news/lotus-eye-hospital-institute-959118"
  },
  "announcements": [
    {
      "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
      "datetime": "28-May-2026",
      "details": "Annual Secretarial Compliance Report for the financial year ended March 31 2026.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "27-May-2026",
      "details": "Newspaper Advertisements published for Standalone Audited Financial Results approved by the Board of Directors at its meeting held on May 26 2026",
      "source": "BSE"
    },
    {
      "caption": "Standalone Audited Financial Results For Quarter And Year Ended March 31 2026",
      "datetime": "26-May-2026",
      "details": "Standalone Audited Financial Results for the quarter and year ended March 31 2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Lotus Eye Hospital & Institute Ltd has declared <strong>5%</strong> dividend, ex-date: 18 Sep 23",
          "dt": "2023-09-18",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Lotus Eye Hospital Gains 0.93%: 4 Key Factors Driving the Week’s Volatility

2026-05-30 14:00:07

Key Events This Week

25 May: Stock opens steady at Rs.107.05 with Sensex rallying 1.23%

26 May: Sharp stock gain of 3.69% to Rs.111.00 despite Sensex decline

27 May: Q4 FY26 results reveal profitability crisis; stock dips 1.62%

29 May: Downgrade to Strong Sell and quality deterioration weigh; stock closes at Rs.108.05 (-1.05%)

Week Open

Rs.107.05

<...

Read full news article

Lotus Eye Hospital & Institute Ltd: Valuation Shifts Signal Elevated Risk Amid Price Attractiveness Decline

2026-05-29 08:02:29

Lotus Eye Hospital & Institute Ltd has seen a marked shift in its valuation parameters, moving from a 'very expensive' to a 'risky' grade, driven by an extraordinary surge in its price-to-earnings ratio and other key multiples. This change signals a significant reassessment of the stock’s price attractiveness relative to its historical and peer benchmarks within the hospital sector.

Read full news article

Lotus Eye Hospital & Institute Ltd Downgraded to Strong Sell Amid Deteriorating Quality Metrics

2026-05-29 08:00:20

Lotus Eye Hospital & Institute Ltd has seen a significant downgrade in its quality grading from average to below average, prompting MarketsMOJO to revise its rating from Sell to Strong Sell as of 27 May 2026. This shift reflects a marked deterioration in key business fundamentals including profitability ratios, debt metrics, and operational consistency, raising concerns for investors despite the stock’s strong long-term returns relative to the Sensex.

Read full news article

Lotus Eye Hospital & Institute Ltd Downgraded to Strong Sell Amid Deteriorating Fundamentals

2026-05-28 08:27:14

Lotus Eye Hospital & Institute Ltd has seen its investment rating downgraded from Sell to Strong Sell as of 27 May 2026, reflecting deteriorating fundamentals across multiple parameters including quality, valuation, financial trends, and technical indicators. The micro-cap hospital sector stock’s recent performance and financial metrics have raised significant concerns among analysts, prompting a reassessment of its outlook.

Read full news article

Are Lotus Eye Hospital & Institute Ltd latest results good or bad?

2026-05-27 20:24:10

Lotus Eye Hospital & Institute Ltd's latest financial results for Q4 FY26 present a complex picture of the company's operational performance. The hospital reported net sales of ₹13.61 crores, reflecting an 18.25% increase year-on-year and a marginal 0.44% growth from the previous quarter. This marks the highest quarterly revenue in the company's recent history, indicating sustained patient demand at its Coimbatore facility. However, this top-line growth has not translated into profitability, as the company recorded a net loss of ₹0.32 crores, a significant shift from a profit of ₹0.25 crores in the same quarter last year. The operating margin has also seen a notable decline, falling to 3.53% from 10.95% in Q1 FY26, highlighting ongoing challenges in managing operational costs effectively. The profit before tax turned negative at ₹0.48 crores, underscoring the erosion of profitability despite the revenue gr...

Read full news article

Lotus Eye Hospital Q4 FY26: Profitability Crisis Deepens Amid Revenue Growth

2026-05-27 11:51:36

Lotus Eye Hospital & Institute Ltd. reported a troubling Q4 FY26 performance, slipping into losses despite achieving its highest-ever quarterly revenue. The Coimbatore-based speciality eye care provider posted a net loss of ₹0.32 crores for the quarter ended March 2026, marking a sharp reversal from the ₹0.25 crores profit recorded in the corresponding quarter last year. The stock has declined 0.38% following the results announcement, trading at ₹109.00 and reflecting investor concerns about deteriorating profitability.

Read full news article

Lotus Eye Hospital & Institute Ltd is Rated Sell

2026-05-19 10:10:22

Lotus Eye Hospital & Institute Ltd is rated Sell by MarketsMOJO. This rating was last updated on 07 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 May 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Lotus Eye Hospital & Institute Ltd Falls 1.20%: Downgrade and Death Cross Signal Weigh on Stock

2026-05-09 14:04:25

Key Events This Week

May 7: Death Cross formation signals potential bearish trend

May 7: Stock rallies 2.77% intraday following technical signal

May 8: Downgrade to Sell rating by MarketsMOJO

May 8: Week closes at Rs.115.05, down 1.20%

Read full news article

Lotus Eye Hospital & Institute Ltd Downgraded to Sell Amid Mixed Fundamentals and Technical Signals

2026-05-08 08:20:46

Lotus Eye Hospital & Institute Ltd has seen its investment rating downgraded from Hold to Sell as of 7 May 2026, reflecting a combination of deteriorating technical indicators, expensive valuation metrics, flat financial trends, and concerns over quality parameters. Despite a strong stock price performance over the past year, the company faces challenges that have prompted a reassessment of its investment appeal.